Genetic predisposition to breast cancer: Past, present, and future

被引:197
作者
Turnbull, Clare [1 ]
Rahman, Nazneen [1 ]
机构
[1] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England
基金
英国医学研究理事会;
关键词
BRCA*; allele; familial; susceptibility; penetrance;
D O I
10.1146/annurev.genom.9.081307.164339
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In recent years, our understanding of genetic predisposition to breast cancer has advanced significantly. Three classes of predisposition factors, categorized by their associated risks of breast cancer, are currently known. BRCA1 and BRCA2 are high-penetrance breast cancer predisposition genes identified by genome-wide linkage analysis and positional cloning. Mutational screening of genes functionally related to BRCA1 and/or BRCA2 has revealed four genes, CHEK2, ATM, BRIP1, and PALB2; mutations in these genes are rare and confer an intermediate risk of breast cancer. Association studies have further identified eight common variants associated with low-penetrance breast cancer predisposition. Despite these discoveries, most of the familial risk of breast cancer remains unexplained. In this review, we describe the known genetic predisposition factors, expound on the methods by which they were identified, and consider how further technological and intellectual advances may assist in identifying the remaining genetic factors underlying breast cancer susceptibility.
引用
收藏
页码:321 / 345
页数:25
相关论文
共 50 条
  • [21] The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition
    Moretta, Jessica
    Berthet, Pascaline
    Bonadona, Valerie
    Caron, Olivier
    Cohen-Haguenauer, Odile
    Colas, Chrystelle
    Corsini, Carole
    Cusin, Veronica
    De Pauw, Antoine
    Delnatte, Capucine
    Dussart, Sophie
    Jamain, Christophe
    Longy, Michel
    Luporsi, Elisabeth
    Maugard, Christine
    Tan Dat Nguyen
    Pujol, Pascal
    Vaur, Dominique
    Andrieu, Nadine
    Lasset, Christine
    Nogues, Catherine
    BULLETIN DU CANCER, 2018, 105 (10) : 907 - 917
  • [22] Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions
    Allweis, Tanir M.
    Hermann, Naama
    Berenstein-Molho, Rinat
    Guindy, Michal
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4306 - 4317
  • [23] HLA DNA typing: past, present, and future
    Erlich, H.
    TISSUE ANTIGENS, 2012, 80 (01): : 1 - 11
  • [24] Biomphalaria alexandrina in Egypt: Past, present and future
    Abou-El-Naga, Iman F.
    JOURNAL OF BIOSCIENCES, 2013, 38 (03) : 665 - 672
  • [25] Hypertension genetics past, present and future applications
    Olczak, Kaya J.
    Taylor-Bateman, Victoria
    Nicholls, Hannah L.
    Traylor, Matthew
    Cabrera, Claudia P.
    Munroe, Patricia B.
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (06) : 1130 - 1152
  • [26] Fanconi anaemia in South Africa: Past, present and future
    Feben, C.
    Wainstein, T.
    Kromberg, J.
    Essop, F.
    Krause, A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (05): : 393 - 398
  • [27] Genomics in coronary artery disease: Past, present and future
    Dandona, Sonny
    Stewart, Alexandre F. R.
    Roberts, Robert
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 56A - 59A
  • [28] Genetics of acute lung injury: past, present and future
    Flores, C.
    Pino-Yanes, M. M.
    Casula, M.
    Villar, J.
    MINERVA ANESTESIOLOGICA, 2010, 76 (10) : 860 - 864
  • [29] Geographical, ethnic, and genetic differences in pancreatic cancer predisposition
    Liew, Sherilyn Zi Hui
    Ng, Kwok Wing
    Ishak, Nur Diana Binte
    Lee, Suat Ying
    Zhang, Zewen
    Chiang, Jianbang
    Ngeow, Joanne Yuen Yie
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (03)
  • [30] Drug-induced liver injury: past, present and future
    Daly, Ann K.
    PHARMACOGENOMICS, 2010, 11 (05) : 607 - 611